Behavioural assessment of dysexecutive syndrome in Parkinson's disease without dementia: A comparison with other clinical executive tasks

被引:28
|
作者
Perfetti, Bernardo [1 ,2 ,3 ]
Varanese, Sara [2 ,3 ,4 ]
Mercuri, Pasqua [5 ,6 ]
Mancino, Elisa [7 ]
Saggino, Aristide [7 ]
Onofrj, Marco [2 ,3 ]
机构
[1] CUNY City Coll, Dept Physiol & Pharmacol, Sch Med, New York, NY 10031 USA
[2] Univ G DAnnunzio, Dept Oncol & Neurosci, Chieti, Italy
[3] Univ Fdn G DAnnunzio, Ctr Excellence Aging, Ce SI, Chieti, Italy
[4] NYU, Dept Neurol, Div Movement Disorders, New York, NY 10016 USA
[5] Univ G DAnnunzio, Dept Clin Sci & Bioimaging, Chieti, Italy
[6] Univ Fdn G DAnnunzio, ITAB, Chieti, Italy
[7] Univ G DAnnunzio, Dept Biomed Sci, Lab Psychometr, Chieti, Italy
关键词
Executive impairments; Neuropsychological test; Six elements test; Tower of London test; Clinical assessment; MINI-MENTAL-STATE; COGNITIVE DYSFUNCTION; SYNDROME BADS; SCHIZOPHRENIA; DEFICITS;
D O I
10.1016/j.parkreldis.2009.07.011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The Behavioural Assessment of the Dysexecutive Syndrome (BADS) is a neuropsychological battery developed with the intent of measuring a wide range of executive impairments. Although the psychometric Characteristics of BADS have previously been investigated in distinct neurological disorders, data on its validity in Parkinson's Disease (PD) without dementia are still lacking. The principal aim of the study was to address this issue. Twenty-five non-demented PD patients and 24 demographically-matched controls were administered BADS and other commonly used executive tools. Comparisons between groups indicated that two of the six BADS subtests (Temporal judgement and Action Program) did not have sufficient sensitivity to executive impairments. However, when we explored group-predictive capabilities among the tests, the BADS total score was the most sensitive, followed by the Tower of London (TOL). We obtained similar results when we disentangled the sensitivity of the six BADS subtests. The BADS Six Elements task was the best group predictor followed by the TOL. Our findings showed that BADS is more sensitive to executive dysfunction than some of the tools commonly used to assess this construct in PD. However, we also demonstrated that, to assess executive impairments in PD without dementia adequately, this battery should be administered in combination with the TOL (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:46 / 50
页数:5
相关论文
共 50 条
  • [41] Characteristics, correlates, and assessment of psychosis in Parkinson disease without dementia
    Barrett, Matthew J.
    Smolkin, Mark E.
    Flanigan, Joseph L.
    Shah, Binit B.
    Harrison, Madaline B.
    Sperling, Scott A.
    PARKINSONISM & RELATED DISORDERS, 2017, 43 : 56 - 60
  • [42] A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies
    Yong, S. W.
    Yoon, J. K.
    An, Y. S.
    Lee, P. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (12) : 1357 - 1362
  • [43] Induction of a transient dysexecutive syndrome in Parkinson's disease using a subclinical dose of scopolamine
    Bédard, MA
    Lemay, S
    Gagnon, JF
    Masson, H
    Paquet, F
    BEHAVIOURAL NEUROLOGY, 1998, 11 (04) : 187 - 195
  • [44] A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies
    Yong, S. W.
    Lee, P. H.
    Kim, Y. J.
    MOVEMENT DISORDERS, 2007, 22 : S234 - S235
  • [45] Longitudinal study of clinical symptoms associated with psychosis in Parkinson's disease without dementia
    Flanigan, J.
    Harrison, M.
    Shah, B.
    Patrie, J.
    Wyman-Chick, K.
    Dalrymple, W.
    Sperling, S.
    Barrett, M.
    MOVEMENT DISORDERS, 2022, 37 : S368 - S368
  • [46] A meta-analysis of executive dysfunction in patients with schizophrenia: Different degree of impairment in the ecological subdomains of the Behavioural Assessment of the Dysexecutive Syndrome
    Thai, Maria Lotus
    Andreassen, Anna Krogh
    Bliksted, Vibeke
    PSYCHIATRY RESEARCH, 2019, 272 : 230 - 236
  • [47] Efficacy of Rivastigmine on Executive Function in Patients with Parkinson's Disease Dementia
    Schmitt, Frederick A.
    Farlow, Martin R.
    Meng, Xiangyi
    Tekin, Sibel
    Olin, Jason T.
    CNS NEUROSCIENCE & THERAPEUTICS, 2010, 16 (06) : 330 - 336
  • [48] Memory and executive function impairment predict dementia in Parkinson's disease
    Levy, G
    Jacobs, DM
    Tang, MX
    Côté, LJ
    Louis, ED
    Alfaro, B
    Mejia, H
    Stern, Y
    Marder, K
    MOVEMENT DISORDERS, 2002, 17 (06) : 1221 - 1226
  • [49] Ecological approach of executive functions using the Behavioural Assessment of the Dysexecutive Syndrome for Children (BADS-C): Developmental and validity study
    Roy, Arnaud
    Allain, Philippe
    Roulin, Jean-Luc
    Fournet, Nathalie
    Le Gall, Didier
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2015, 37 (09) : 956 - 971
  • [50] Neuropsychological assessment of mild to moderate stage Parkinson's disease without dementia: Comparison with mild stage of Alzheimer's disease (AD) - a preliminary study
    Kim, Y. D.
    Kim, J. E.
    Kim, J. H.
    MOVEMENT DISORDERS, 2007, 22 : S189 - S189